Farallon Capital Management’s Telix Pharmaceuticals TLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.6M Buy
+419,000
New +$4.75M 0.02% 101

Other funds holding TLX

Farallon Capital Management's TLX Position: Q3 2026 in Review

Farallon Capital Management opened a new position in Telix Pharmaceuticals (TLX) in Q3 2026: 419,000 shares worth $4.6M. The stake represents 0.02% of the portfolio and ranks #101 among its holdings.

71 funds tracked by Wall St. Rank hold TLX as of Q3 2026.

  • Farallon Capital Management held 419,000 shares of Telix Pharmaceuticals worth $4.6M as of Q3 2026.
  • Telix Pharmaceuticals was a new Farallon Capital Management position in Q3 2026.
  • Telix Pharmaceuticals made up 0.02% of Farallon Capital Management's portfolio in Q3 2026, its #101 holding.
  • 71 funds tracked by Wall St. Rank held Telix Pharmaceuticals as of Q3 2026.

Based on Farallon Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.